<a href="${link:{uuid:{55f30477-c7e2-49c0-8cfc-16966f28d4c2},repository:{dam},path:{/Portal/UK/Prescribing-links/Praluent-PI-GB-October-2022.pdf}}}" target="_blank">Prescribing Information(GB)</a>

<a href="${link:{uuid:{9e0d6f97-2ebb-4422-92ab-569b89c7dfe0},repository:{dam},path:{/Portal/UK/Prescribing-links/Praluent-PI-NI.pdf}}}" target="_blank">Prescribing Information(NI)</a>

Disclaimer: The resources contained within this section are updated regularly by Sanofi. Before you use any of the resources, or provide any resources to your patients please re-visit this page to ensure that you are using the most up-to-date version(s).
Order patient materials either via your local representative or Contact Medical Information on +44 (0) 800 035 2525 (Monday – Friday, 8:30-17:30, excluding public holidays)
<h2>Training materials</h2>

<h3>RESOURCES FOR PRALUENT®&nbsp;75MG OR 150MG</h3>

DYSLIPIDEMIA

CARDIOLOGY

Praluent® (alirocumab) Patient Resources

▶&nbsp;How to Inject Praluent®&nbsp;(video)

▶&nbsp;Digital Starter Pack (PDF)

▶ Praluent&reg;&nbsp;Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

<h3>RESOURCES FOR PRALUENT®&nbsp;300MG</h3>

▶ How to Inject Praluent®&nbsp;(video)

Website: MyPraluent&reg;&nbsp;- This website was developed and funded by Sanofi

Patient Information Leaflet 75mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information leaflet 300mg (sourced from&nbsp;Medicines.org.uk)

Disclaimer: The above resources should be downloaded and given to your patient(s) who have been prescribed Praluent®, or can be shown to your patient(s) during consultation. Your patient(s) must not be directed towards this website as it is intended for healthcare professionals only.

<a href="/uk/dyslipidaemia">SEE MORE FROM SCIENCE</a>

<h3>Praluent®</h3>
Find more information on Indication, Administration and Mechanism of Action and watch videos about Praluent®.

<h3>Patient Website</h3>
Find resources and support for your patients on Praluent®. Find useful links about how patients can manage their cholesterol.

Get in touch with the Dyslipidaemia Team

Praluent® (alirocumab) Prescribing Information (GB)

Praluent® (alirocumab) Prescribing Information (NI)

Disclaimer: The resources contained within this section are updated regularly by Sanofi. Before you use any of the resources, or provide any resources to your patients please re-visit this page to ensure that you are using the most up-to-date version(s).

▶ Praluent&reg; Injection Guide (PDF)

Praluent® (alirocumab) - Comprehensive Support for the Praluent® Patient

<h3>Patient Profiles</h3>

Read the patients profiles you are likely to encounter in your practice who could be eligible for Praluent®.

Homecare is run by experienced pharmacists who dispense Praluent®&nbsp;and arrange delivery to patients.

<h3>MyPraluent®&nbsp;Coach</h3>
MyPraluent®&nbsp;Coach is a free 6-12 month programme designed with input from healthcare professionals and patients prescribed Praluent®&nbsp;and is delivered by experienced nurses.

More about MyPraluent® Coach

<a>More about Praluent®</a>

<a href="${link:{uuid:{e506abb5-a59a-476f-b5c0-20cc50c86a65},repository:{dam},path:{/Portal/UK/Prescribing-links/praluent-gb-pi.pdf}}}">Prescribing Information(GB)</a>

MyPraluent®&nbsp;Coach is a free 6–12 month programme designed with input from healthcare professionals and patients and is delivered by experienced nurses
*MyPraluent®&nbsp;Coach is provided and funded by Sanofi
<ul>
 <li>This patient support programme is a post-prescription service and only available to patients prescribed Praluent®</li>
 <li>To enrol your Praluent®&nbsp;patients please contact your local Sanofi representative</li>
</ul>
Not all hospitals will utilise My Praluent®&nbsp;Coach, please confirm your own situation
Contact Details for My Praluent®&nbsp;Coach Providers:
Ashfield 
 Our Ashfield services have been closed as of end August 2024 and all patients have either been transferred to either Sciensus or Healthnet, or have chosen to be managed directly by their physician. There will not be any new patient registrations with Ashfield.
HealthNet 
 ✉&nbsp;&nbsp;<a href="mailto:enquiries@healthnethomecare.co.uk">enquiries@healthnethomecare.co.uk</a> 
 ☎&nbsp;&nbsp;0800 083 3060
Sciensus 
 ✉ <a href="mailto:generalenquiries@sciensus.com">generalenquiries@sciensus.com</a> 
 ☎ 0333 103 9499

MyPraluent® (alirocumab) COACH

<h2>Sanofi contracts a Homecare provider to provide homecare services free of charge</h2>
Homecare is run by experienced pharmacists who dispense Praluent®&nbsp;and arrange delivery to patients.

<ul>
 <li>In the NHS, homecare services support a range of benefits to key stakeholders</li>
 <li>Homecare services are available to individual hospitals upon signature of a Service Level Agreement</li>
</ul>
Not all hospitals will utilise our Homecare service, please confirm your own situation
Contact Details for Homecare Providers
Sciensus
✉&nbsp;&nbsp;<a href="mailto:generalenquiries@sciensus.com">generalenquiries@sciensus.com</a> 
 ☎&nbsp;&nbsp;0333 103 9499
HealthNet
✉&nbsp;&nbsp;<a href="mailto:enquiries@healthnethomecare.co.uk">enquiries@healthnethomecare.co.uk</a> 
 ☎&nbsp;&nbsp;0800 083 3060

Praluent® (alirocumab) Homecare Services

<h3>Second&nbsp;MI</h3>
6&nbsp;weeks&nbsp;ago
Age:&nbsp;55&nbsp;years 
 LDL-C:&nbsp;3.6&nbsp;mmol/L&nbsp; Polyvascular&nbsp;disease&nbsp;&nbsp;(CAD&nbsp;&amp;&nbsp;PAD)&nbsp; Smoker

<h3>First&nbsp;MI</h3>
6 months ago
Age:&nbsp;63&nbsp;years 
 LDL-C:&nbsp;4.1&nbsp;mmol/L No additional comorbidities or family history of heart disease 
 Non-smoker

<h3>First&nbsp;MI</h3>
12 months ago
Age:&nbsp;63&nbsp;years 
 LDL-C:&nbsp;5.0&nbsp;mmol/L Familial&nbsp;hypercholesterolaemia&nbsp; Non-smoker

Any ACS means the patient is at very high CV risk, regardless of comorbidities1

Praluent® (alirocumab) Patient profiles

<h4><a href="https://pro.campus.sanofi/dam/Portal/UK/Prescribing-links/Dupixent-AD-and-PN-GB-PI.pdf" target="_blank">Prescribing Information GB</a></h4>

<h4><a href="https://pro.campus.sanofi/dam/Portal/UK/Prescribing-links/Dupixent-AD-and-PN-PI-IE-XI.pdf" target="_blank">Prescribing Information NI/ROI</a></h4>

<h5>Disclaimer: The above resources should be downloaded and given to your patient(s) who have been prescribed DUPIXENT®.&nbsp; Additionally, once prescribed, the patient materials give them access to the patient website <a href="https://www.dupixentmyway.co.uk" target="_blank">www.dupixentmyway.co.uk</a>. Your patient(s) must not be directed towards this website as it is intended for healthcare professionals only.</h5>

<h2 style="color:#00A780;">Patient Support - Atopic Dermatitis</h2>
<h4 style="color:#00A780;">What is DUPIXENT Patient Support?</h4>
The DUPIXENT Patient Support Programme, DUPIXENT MyWay, is designed to help enrolled Patients achieve optimum levels of adherence and increase levels of self-confidence and ability to manage both their condition and treatment regimen.&nbsp;&nbsp;&nbsp;
With DUPIXENT MyWay, our goal is to encourage your patients to make effective use of DUPIXENT.
With more on-demand and digital touchpoints we are giving your patients relevant tools &amp; information when they need it to support and educate them on their DUPIXENT treatment.&nbsp; 
 &nbsp;

<h3 style="color:#00A780; text-align: center;">Dispense and delivery</h3>
<ul>
 <li>Prescription management by your homecare provider</li>
 <li>They will arrange deliveries against an active prescription</li>
 <li>They will check the patient's stock when delivering and flag any medication adherence concerns</li>
</ul>

<h3 style="color:#00A780; text-align: center;">Nurse-led injection training</h3>
<ul>
 <li>Trained homecare nurses to help your patients or their carers be confident and competent in all aspects of self-administration&nbsp;</li>
 <li>Educate your DUPIXENT patients on how to get the best from the support available</li>
 <li>Virtual nursing is available for all patients</li>
</ul>

<h3 style="color:#00A780; text-align: center;">Patient support programme</h3>
<ul>
 <li>Designed to inform and motivate your patients to maintain therapy &nbsp;</li>
 <li>Including ongoing support calls, digital notifications, and injection day reminders</li>
</ul>

<h3 style="color:#00A780;">How to ensure your patient is signed up to the PSP?</h3>
Once you have made the decision to prescribe, to ensure that your patients can benefit from all aspects of the DUPIXENT MyWay Patient Support Programme, please tick the box for PSP on the homecare registration form.

Please also give your patient or their carer the Home Delivery and Patient Support Service leaflet which can be found in the Patient Support Resource section below, designed to let your patients know what to expect from the service.

<h3 style="color:#00A780">DUPIXENT Patient Support journey</h3>
<h4 style="color:#00A780">Homecare</h4>

<h3 style="color:#00A780">Patient support programme</h3>

<h3 style="color:#00A780">Injection Videos</h3>
It's important patients and carers feel comfortable and prepared for injecting DUPIXENT, so we've developed videos to help support.

<h2 style="color:#00A780">Patient Support Resources</h2>
<h3 style="color:#00A780">Patient Website</h3>
Find resources and support for your patients on DUPIXENT. This Includes information about treatment, how to inject guides, travelling with DUPIXENT information and support resources.

ATOPIC-DERMATITIS

DERMATOLOGY

<h5>All patients starting treatment on Homecare services will receive a starter pack with the all the above resources to their home.</h5>

Patient Support Resources

Paediatric Patient Support Resources

Order materials packs for your patients who are being prescribed DUPIXENT either via your local representative or Contact Medical Information on +44 (0) 800 035 2525 (Monday – Friday, 8:30-17:30, excluding public holidays).

Prescribing Information GB

Prescribing Information NI/ROI

DUPIXENT® (dupilumab) Atopic Dermatitis Patient Support Resources

If you prefer to speak to someone when ordering vaccines our customer service team is available to help you weekdays from 9am to 5pm.

Call us for vaccines ordering on the number below or&nbsp;<a href="https://pro.campus.sanofi/uk/general-topics/articles/contact-vaccines">request a call back</a>.

<a href="https://www.vaxishop.co.uk/vaxishop/en/GBP/login?site=vaxishop&amp;utm_source=campus-way-to-order&amp;utm_medium=website&amp;utm_campaign=qiv-hd&amp;utm_term=text-link" target="_blank">VaxiShop</a>&nbsp;is our simple to use vaccines ordering site.

It allows you to conveniently and efficiently&nbsp;place vaccines orders, set up&nbsp;vaccine standing orders,&nbsp;track deliveries, manage invoices, and view your order history.

Some of our paediatric vaccines are available on the national immunisation programme and can be easily ordered through&nbsp;<a href="https://portal.immform.phe.gov.uk/Logon.aspx?returnurl=%2f">ImmForm</a>.

ImmForm is a UKHSA website which provides vaccine ordering facilities for the national immunisation programme.

<h2>Vaccine Standing Order (VSO) benefits</h2>
Our Vaccine Standing Order (VSO) is tailored to your vaccine requirements to help you place and manage orders with ease, flexibility and peace of mind.&nbsp;
With this in place, you will have priority access to your chosen vaccines at times of the year when you need them most.
It's also easy to update your VSO if requirements change via VaxiShop or by&nbsp;<a href="https://pro.campus.sanofi/uk/general-topics/articles/contact-vaccines">contacting us</a>.

You can easily alter, amend or postpone a delivery, if necessary, to meet your changing vaccine requirements.

You receive a discount per vaccine based on your annual order rather than per delivery for maximum savings.

You can set up recurring orders, manage stock, track deliveries and access regular invoices efficiently online.

As a priority customer your supply will be protected in the event of supply disruption, giving you peace of mind and the confidence to maintain an effective service.

<h2>Flu Vaccines Returns</h2>
We understand that forecasting the number of influenza vaccines you need in any given season is never easy. That's why we offer a&nbsp;"take-back service"&nbsp;giving you peace of mind that&nbsp;a percentage&nbsp;of any Sanofi flu order can be returned free of charge at the end of the flu season if it remains unused in your fridge.&nbsp;

Get in touch with the Vaccines Team

OTHER-VACCINES-TOPICS

VACCINES

Ways to Order

<h2>Verorab® Inactivated Rabies Vaccine</h2>
<a href="${link:{uuid:{51de6efc-84f2-4b28-945f-ca015b393e48},repository:{dam},path:{/Portal/UK/Prescribing-links/Verorab-PI-GB.pdf}}}">Prescribing Information - GB</a>
<a href="${link:{uuid:{00c041a2-8e01-45cb-ad78-82300638e144},repository:{dam},path:{/Portal/UK/Prescribing-links/Verorab-PI-NI.pdf}}}">Prescribing Information - NI</a>
Rabies kills almost 60,000 people every year – which is roughly 1 person every 9 minutes1
Travel related rabies deaths are 100% preventable through timely pre- and post-exposure measures.2,3

Rabies - Patient Experience:&nbsp;

Rabies - Risk for Travellers:&nbsp;&nbsp;

Prescribing Information (GB)

Prescribing Information (NI)

TRAVEL

Rabies Support Materials 

Welcome to your Health System Collaboration Portal. Whether you are focused on population health management, service design or budget planning, you can find here tools to address health inequalities and improve patient outcomes. Get quick access to product information, useful resources from therapy support to treatment guidelines, formulary and service support across various therapy areas.
Our field representatives are here to offer you a personalized support: from improving access to healthcare services to capability building, our team can help design and implement strategies to reduce inequalities in your region.

<h4>Get in touch and discuss with your local representative</h4>

<h4>To unlock content tailored to your locality and receive emails about our products and services</h4>

<h3>Let’s Be Sustainable</h3>
The NHS is one of the world’s first healthcare systems to explicitly put sustainability in its targets which, as a committed NHS partner, we are supporting in numerous ways.

<h3>Formulary and Service Support</h3>
Resources designed to inform, aid and give you a higher level of insight into specific therapy areas, and to help you design and implement strategies to reduce inequalities in healthcare.

Sanofi undertakes collaborative working projects for the benefit of patients and/or the NHS. These projects are entirely non promotional and are not linked in any way to any of our products.

<h3>Let's Be Collaborative and Transformative</h3>
Explore collaborative working case studies and discover how Sanofi has been working in partnership with the NHS to deliver optimised care across the UK.

Get in Touch with the Health System Solutions Team

PAYOR

OUT-OF-TAXONOMY

Health System Collaboration Portal

To read this content, please activate your Sanofi Campus account via the email we've sent to you.

If you didn't receive our first email at {email} to confirm your account you can request a new one below. If you don't see it, you may need to check your spam folder.

title

In order to see relevant content, tell us what you are interested in

Title

Create new password

complete your profile to help us provide you with content that's relevant to you.

Your profile is incomplete

Development of ADCT involved literature review as well as interviews with patients and physicians, and was funded by Sanofi and Regeneron.

The ADCT gives a measure of how controlled your patient’s eczema is. Use these 6 concise questions to evaluate all dimensions of atopic dermatitis control.

Atopic dermatitis, a type of eczema, may be affecting your patient’s life in more ways than you know.

Enjoy more exclusive content{newline}by <a>registering today</a>

MAT-XU-2300297 (v3.0) - Date of preparation: October 2023

MAT-XU-2305062 (v1.0) - Date of preparation: November 2023

MAT-XU-2300297 (v3.0) Date of Preparation: October 2023

MAT-XU-2305047 (v1.0) - Date of preparation: November 2023

Already have an account? <a>Sign in here</a>

Best practices on optimising patient care

Get a customised view of the topics that you're interested in, along with the ability to save content to watch or read at a later date.

Unlimited access to premier content, white papers, case studies, research papers, webinars, training, and up-to-date scientific medical resources.

Personalised content based on your areas of interest

Connect and stay up-to-date with peers in your area of speciality and topics of interest through free events and leadership forums.

Please sign in to continue and read the full article

Please sign up to continue reading the full article.

We respect your privacy and will not share your information with any 3rd parties.

Topical guides written specifically for patients

Unlimited access to the latest patient guide guides and resources. Share content with your patients with easy-to-use online tools.

Please complete your profile to read the content.

Your profile is not validated yet. Please verify your inbox.

Restricted Access

We can't find the page you're looking for

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

You are about to leave Sanofi Campus website.

You are now leaving this site to visit a partner website.

Thank you for visiting COPD Sanofi Campus.

This website is for healthcare professionals only.

Welcome to COPD Sanofi Campus.

Welcome to COPD Sanofi Campus

Please refresh the page to access the content

Sorry, something went wrong

The page you are looking for may be under maintenance, or the link may be incorrect.

Sorry, we can't find this page

You are going to a website that is not operated by Sanofi or a Sanofi website where the terms of use may differ. For external websites, Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party or Sanofi sites.

You are now leaving the Sanofi campus UK website

You are about to leave Campus.sanofi/uk.

Thank you for registering. Before we get started, we need to confirm your email address to ensure that we have the correct information.

Please follow these steps to complete your registration:

Would you like to receive future text messages about Beyfortus updates?

Sanofi is here to help support your patients, their families, and caregivers. For more information regarding Beyfortus®, call <a.callPhoneNumberBeyfortus>1-855-BEYFORTUS (1-855-239-3678)</a.callPhoneNumberBeyfortus> or sign up below to receive the latest updates via email or text. All fields are required.

Would you like to learn more about Beyfortus® (nirsevimab-alip) 50 mg and 100 mg injection? Leave us your contact details, and a Sanofi representative will be in touch.

Do you want to participate in the Beyfortus Reservation Program?

What information are you interested in learning more about? (Optional)

Request a visit from your local ALPROLIX representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local ALTUVIIIO representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local QFITLIA representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your ALPROLIX® Representative or receive updates about ALPROLIX. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your QFITLIA Representative or receive updates about QFITLIA. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

This site is intended for UK healthcare professionals only and contains information on Sanofi UK's medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a UK healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

MAT-XU-2300297 (v6.0) - Date of Preparation: April 2024

Welcome to Sanofi Campus UK

This content is only available to registered users. Please sign in or register to view this content.

Please Sign In

Email verification

You're seeing a preview of the portal. Clear your cookies (by closing your browser window for example) to go back to public mode.

We've updated our privacy notice to better protect your data and enhance your experience. Please take a moment to review the changes by <privacyNewTab>clicking here</privacyNewTab>. Your privary matters for us. Please click on continue to confirm you have read the new privacy notice.

Privacy Notice Update

Communication consent

My Consent

{resultsCount, plural, one {result} other {results}}

Please sign in to access to the results

You need to sign-in to your account in order to access medical content.

To access the results, please register in under 1 minute

You are now leaving the Sanofi content section of our site and entering the external medical bibliographic search content section.

You are entering to the External Scientific Content Site

You are now leaving the external medical bibliographic search section of our site and entering the Sanofi content section.

Latest Resources